Impact of Proton Pump Inhibitor Use on 90-Day and 2-Year Postoperative Complications Following Intermedullary Nailing for Intertrochanteric Femur Fractures and ORIF for Proximal Humerus Fractures: A Retrospective Cohort Study
Abstract Purpose: To evaluate the association between proton pump inhibitor (PPI) and postoperative outcomes following intermedullary nailing (IMN) of intertrochanteric femur fractures and open reduction internal fixation (ORIF) of proximal humerus fractures. Methods: Two parallel retrospective cohort analyses were performed using the TriNetX Research Network. Adults (>18 y/o) undergoing IMN for intertrochanteric fractures (n=10,605 per cohort) or ORIF for proximal humerus fractures (n=3,114 per cohort) were grouped by PPI use within 90 days preoperatively. Propensity score matching balanced demographic and clinical characteristics. Outcomes were assessed within 90 days and 2 years postoperatively, reported as risk ratios (RR) with significance as p<0.05. Results: After IMN, PPI use was associated with an increased risk of pulmonary embolism (RR:1.4, p=0.014), acute kidney injury (RR:1.3, p=0.001), and myocardial infarction (RR:1.3, p=0.033 at 90-days follow-up. At 2-years, PPI use was linked to higher rates of deep vein thrombosis (RR:1.1, p=0.031), acute kidney injury (RR:1.2, p=0.006), and pneumonia (RR:1.1, p=0.010). After ORIF, PPI use within 90 days postoperatively was associated with wound disruption (RR:1.7, p=0.05), infection (RR:1.8, p=0.002), deep vein thrombosis (RR:1.8, p=0.026), and pulmonary embolism (RR:2.8, p=0.003). At the 2-years, PPI users experienced increased risks of infection (RR:1.5, p=0.003), DVT (RR:1.8, p=0.002), PE (RR:1.8, p=0.019), UTI (RR:1.3, p=0.022), nonunion (RR:1.7, p=0.004), and malunion (RR:2.1, p=0.025). Conclusion: PPI use is associated with adverse postoperative outcomes following IMN of intertrochanteric fractures and ORIF for proximal humerus fractures. Prospective studies are needed to clarify the causal relationships and isolate the effect of PPI use on postoperative outcomes.
Authors
- Yousef Tanas (ORCID: https://orcid.org/0000-0001-5189-2027)
- Roxana Zaman
- Keenan Horani (ORCID: https://orcid.org/0009-0008-4947-772X)
- Kerollos Ibrahim (ORCID: https://orcid.org/0009-0000-0954-1135)
- Daniel Cho
- Philong Nguyen (ORCID: https://orcid.org/0009-0002-4259-4129)
- William Weiss
- Krish Patel (ORCID: https://orcid.org/0009-0008-1376-3249)
- Josh Wang
Institutions
- Houston Methodist (US)
- Rothman Orthopaedics (US)
- The University of Texas Medical Branch at Galveston (US)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-13
- DOI
- https://doi.org/10.21203/rs.3.rs-11435174/v1
- Primary Topic
- Hip and Femur Fractures
- Type
- preprint